Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TVGN Tevogen Bio Holdings Inc.
- Stocks
- Healthcare
- NASDAQ: TVGN
Price (delayed)
$1.3
Market cap
$239.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.2
Enterprise value
$241.91M
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN
Highlights
The company's quick ratio has surged by 50% QoQ and by 41% YoY
The EPS has plunged by 186% from the previous quarter but it has grown by 26% YoY
The debt has soared by 132% YoY and by 67% from the previous quarter
The net income has dropped by 66% year-on-year
Key stats
What are the main financial stats of TVGN
Market
Valuations
Earnings
Shares outstanding
183.89M
Market cap
$239.06M
Enterprise value
$241.91M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$34.4M
Net income
-$31.9M
EBIT
-$31.85M
EBITDA
-$31.43M
Free cash flow
-$13.14M
Per share
Balance sheet
Liquidity
EPS
-$0.2
EPS diluted
-$0.2
Free cash flow per share
-$0.08
Book value per share
-$0.04
Revenue per share
$0
TBVPS
$0.03
Total assets
$4.07M
Total liabilities
$11.79M
Debt
$4.82M
Equity
-$7.72M
Working capital
-$5.64M
Debt to equity
-0.62
Current ratio
0.35
Quick ratio
0.24
Net debt/EBITDA
-0.09
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-843.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TVGN stock price
How has the Tevogen Bio Holdings stock price performed over time
Intraday
1.56%
1 week
-0.76%
1 month
28.71%
1 year
65.67%
YTD
26.21%
QTD
20.37%
Financial performance
How have Tevogen Bio Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$34.4M
Net income
-$31.9M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 66% year-on-year
The operating income has increased by 44% since the previous quarter and by 21% year-on-year
Price vs fundamentals
How does TVGN's price correlate with its fundamentals
Growth
What is Tevogen Bio Holdings's growth rate over time
Valuation
What is Tevogen Bio Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 186% from the previous quarter but it has grown by 26% YoY
Tevogen Bio Holdings's equity has decreased by 33% YoY and by 16% QoQ
Efficiency
How efficient is Tevogen Bio Holdings business performance
The return on assets has dropped by 196% since the previous quarter
Dividends
What is TVGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TVGN.
Financial health
How did Tevogen Bio Holdings financials performed over time
TVGN's total assets is 65% lower than its total liabilities
The company's quick ratio has surged by 50% QoQ and by 41% YoY
TVGN's current ratio is up by 35% since the previous quarter and by 30% year-on-year
The debt is 162% more than the equity
The debt has soared by 132% YoY and by 67% from the previous quarter
The debt to equity has shrunk by 72% YoY and by 44% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.